赵保胜, 刘洋, 徐暾海. 人参皂苷Rg1对人胃癌 BGC-823的抑制作用研究[J]. 中国临床药理学与治疗学, 2011, 16(4): 361-365. [2]曲惠青, 刁汇玲, 张慧, 等. 人参皂甙Rg1对人慢性粒细胞白血病 p210 bcr/abl融合蛋白表达的影响[J]. 现代生物医学进展, 2010, 10(10): 1851-1853. [3]Ghezzi P, Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine[J]. Cell Death Differ, 2004, 11(Suppl 1): S37-S44. [4]Koury M J, Bondurant M C. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells[J]. Science, 1990, 248(4953): 378-381. [5]Schuster S J, Koury S T, Bohrer M, et al. Cellular sites of extrarenal and renal erythropoietin production in anaemic rats[J]. Br J Haematol, 1992, 81(2): 153-159. [6]陈地龙, 刘永刚, 王亚平, 等. 人参多糖对K562细胞增殖抑制及诱导分化的实验研究[J]. 第三军医大学学报, 2005, 27(6): 517-520. [7]王金良, 孔佩艳, 徐葳, 等. 人参皂苷Rg3抑制急性白血病骨髓基质细胞HIF-1α及VEGF的表达及其机制探讨[J]. 第三军医大学学报, 2010, 32(7): 621- 624. [8]刘晓岩, 李静, 王建伟, 等. 人参总皂甙对白血病细胞KG1α增殖、凋亡的影响[J]. 第三军医大学学报, 2010, 32(24): 2599-2603. [9]Hedley B D, Allan A L, Xenocostas A. The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression[J]. Clin Cancer Res, 2011, 17(20): 6373-6380. [10]Kertesz N, Wu J, Chen T H, et al. The role of erythropoietin in regulating angiogenesis[J]. Dev Biol, 2004, 276(1): 101-110. [11]Christopherson K W 2nd, Hangoc G, Broxmeyer H E. Cell surface peptidase CD26/dipeptidylpeptidase Ⅳ regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells[J]. J Immunol, 2002, 169(12): 7000-7008. [12]Christopherson K W 2nd, Hangoc G, Mantel CR, et al. Modulation of hematopoietic stem cell homing and engraftment by CD26[J]. Science, 2004, 305(5686): 1000-1003. [13]Dev A, Byrne S M, Verma R, et al. Erythropoietin-directed erythropoiesis depends upon serpin inhibition of erythroblast lysosomal cathepsins[J]. J Exp Med, 2013, 210(2): 225-232. [14]Hand C C, Brines M. Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?[J]. J Investig Med, 2011, 59(7): 1073- 1082. [15]Alas S, Bonavida B. Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin’s lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs[J]. Cancer Res, 2001, 61(13): 5137- 5144. [16]胡作为, 周燕萍, 沈自尹. p16基因与细胞衰老关系的研究进展[J]. 国外医学: 遗传学分册, 2004, 27(4): 200-202. [17]Chen Z, Trotman L C, Shaffer D, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis[J]. Nature, 2005, 436(7051): 725-730. [18]Collado M, Gil J, Efeyan A, et al. Tumour biology: senescence in premalignant tumors[J]. Nature, 2005, 436(7051): 642. [19]Phatak P, Burger A M. Telomerase and its potential for therapeutic intervention[J]. Br J Pharmacol, 2007, 152(7): 1003-1011.
